Published on in Vol 21 , No 11 (2019) :November
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/13371, first published
.

Journals
- Peng W, Zhao Y, Wang Y, Wang J, Hao Q, Tu Y, Zhu T. Comparison between acupuncture and cognitive behavioral therapy for primary insomnia. Medicine 2020;99(21):e20453 View
- Siclari F, Valli K, Arnulf I. Dreams and nightmares in healthy adults and in patients with sleep and neurological disorders. The Lancet Neurology 2020;19(10):849 View
- Langade D, Thakare V, Kanchi S, Kelgane S. Clinical evaluation of the pharmacological impact of ashwagandha root extract on sleep in healthy volunteers and insomnia patients: A double-blind, randomized, parallel-group, placebo-controlled study. Journal of Ethnopharmacology 2021;264:113276 View
- Trajanović N. Dual orexin receptor antagonist in treatment of insomnia. Engrami 2020;42(2):57 View
- Feipeng G, Luxin X, Beili C, Songhong Y, Wenting W, Junmao L, Qianfeng G, Lingyun Z, Jianxiong W, Huang J. Exploration of Ziziphi Spinosae Semen in Treating Insomnia Based on Network Pharmacology Strategy. Evidence-Based Complementary and Alternative Medicine 2021;2021:1 View
- Gordijn R, Wessels W, Kriek E, Nicolai M, Elzevier H, Visser L, Guchelaar H, Teichert M. Patient reporting of sexual adverse events on an online platform for medication experiences. British Journal of Clinical Pharmacology 2022;88(12):5326 View
- Yoshioka R, Yamamoto S, Nakatani E, Yasui-Furukori N. Effectiveness of suvorexant versus benzodiazepine receptor agonist sleep drugs in reducing the risk of hip fracture: Findings from a regional population-based cohort study. PLOS ONE 2023;18(4):e0284726 View
Books/Policy Documents
- Haghparast P, Pondrom M, Ray S. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. View